Wolf Popper LLP Files Class Action Lawsuit Against American Renal Associates Holdings, Inc.
Sep 06, 2016 12:45 pm UTC| Business
NEW YORK, Sept. 06, 2016 -- Wolf Popper LLP has filed a class action lawsuit against American Renal Associates Holdings, Inc. (“American Renal”) (NYSE:ARA), and certain of its officers, in the United States District...
Sep 06, 2016 12:45 pm UTC| Business
BEIJING, Sept. 06, 2016 -- Wowo Limited (the “Company”) (NASDAQ:JMU), a leading B2B online e-commerce platform that provides integrated services to suppliers and customers in the foodservice industry in China, today...
Sep 06, 2016 12:45 pm UTC| Business
TUSTIN, Calif., Sept. 06, 2016 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology...
Energy Focus, Inc. Dimmable LED Honored in FEMP Call for Innovation
Sep 06, 2016 12:45 pm UTC| Business
SOLON, Ohio, Sept. 06, 2016 -- Energy Focus, Inc. (NASDAQ:EFOI), a leader in LED lighting technologies, was recently awarded second place in a Federal Energy Management Program (FEMP) Call for Innovation competition....
First Large-Scale CLARISOY™ Production Facility Scheduled to be Commissioned in Fourth Quarter
Sep 06, 2016 12:38 pm UTC| Business
VANCOUVER, British Columbia, Sept. 06, 2016 -- Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon”) announced today that, Archer Daniels Midland Company (NYSE:ADM), Burcon’s license and production partner...
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
Sep 06, 2016 12:38 pm UTC| Business
ALBANY, N.Y., Sept. 06, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today...
Versartis to Present at the Morgan Stanley Global Healthcare Conference
Sep 06, 2016 12:35 pm UTC| Business
MENLO PARK, Calif., Sept. 06, 2016 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...